307 related articles for article (PubMed ID: 29042026)
1. Identification, signaling, and functions of LTB
Saeki K; Yokomizo T
Semin Immunol; 2017 Oct; 33():30-36. PubMed ID: 29042026
[TBL] [Abstract][Full Text] [Related]
2. Two distinct leukotriene B4 receptors, BLT1 and BLT2.
Yokomizo T
J Biochem; 2015 Feb; 157(2):65-71. PubMed ID: 25480980
[TBL] [Abstract][Full Text] [Related]
3. A turn on and a turn off: BLT1 and BLT2 mechanisms in the lung.
Watanabe M; Machida K; Inoue H
Expert Rev Respir Med; 2014 Aug; 8(4):381-3. PubMed ID: 24742066
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene B
Hirakata T; Matsuda A; Yokomizo T
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158756. PubMed ID: 32535236
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells.
Lundeen KA; Sun B; Karlsson L; Fourie AM
J Immunol; 2006 Sep; 177(5):3439-47. PubMed ID: 16920986
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins.
Ishii Y; Saeki K; Liu M; Sasaki F; Koga T; Kitajima K; Meno C; Okuno T; Yokomizo T
FASEB J; 2016 Feb; 30(2):933-47. PubMed ID: 26527063
[TBL] [Abstract][Full Text] [Related]
7. 12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor.
Liu M; Saeki K; Matsunobu T; Okuno T; Koga T; Sugimoto Y; Yokoyama C; Nakamizo S; Kabashima K; Narumiya S; Shimizu T; Yokomizo T
J Exp Med; 2014 Jun; 211(6):1063-78. PubMed ID: 24821912
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic target of leukotriene B
Nakamura M; Shimizu T
Biochimie; 2023 Dec; 215():60-68. PubMed ID: 37423557
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in function and structure of two leukotriene B
Nakamura M; Shimizu T
Biochem Pharmacol; 2022 Sep; 203():115178. PubMed ID: 35850310
[TBL] [Abstract][Full Text] [Related]
10. Macrophage LTB
Zhang Y; Olson RM; Brown CR
J Lipid Res; 2017 Mar; 58(3):494-503. PubMed ID: 28053185
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
[TBL] [Abstract][Full Text] [Related]
12. The role of the LTB
Subramanian BC; Majumdar R; Parent CA
Semin Immunol; 2017 Oct; 33():16-29. PubMed ID: 29042024
[TBL] [Abstract][Full Text] [Related]
13. The yin and yang of leukotriene B
Jala VR; Bodduluri SR; Satpathy SR; Chheda Z; Sharma RK; Haribabu B
Semin Immunol; 2017 Oct; 33():58-64. PubMed ID: 28982616
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene B4 receptors.
Toda A; Yokomizo T; Shimizu T
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():575-85. PubMed ID: 12432944
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia.
Matsunaga Y; Fukuyama S; Okuno T; Sasaki F; Matsunobu T; Asai Y; Matsumoto K; Saeki K; Oike M; Sadamura Y; Machida K; Nakanishi Y; Kubo M; Yokomizo T; Inoue H
FASEB J; 2013 Aug; 27(8):3306-14. PubMed ID: 23603839
[TBL] [Abstract][Full Text] [Related]
16. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
17. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.
Yokomizo T; Kato K; Terawaki K; Izumi T; Shimizu T
J Exp Med; 2000 Aug; 192(3):421-32. PubMed ID: 10934230
[TBL] [Abstract][Full Text] [Related]
18. 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2.
Okuno T; Iizuka Y; Okazaki H; Yokomizo T; Taguchi R; Shimizu T
J Exp Med; 2008 Apr; 205(4):759-66. PubMed ID: 18378794
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and biological functions of 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid.
Okuno T; Yokomizo T
Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106502. PubMed ID: 33075476
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes.
Iizuka Y; Yokomizo T; Terawaki K; Komine M; Tamaki K; Shimizu T
J Biol Chem; 2005 Jul; 280(26):24816-23. PubMed ID: 15866883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
